Direct healthcare professional communications: A quantitative assessment study

Alsaleh, Hajar Mohmmed; Alshammari, Thamir M

doi:10.1002/prp2.763

Cited by 2 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, hyperkalemia associated with RAASi medications and cardiac risks was the most frequent safety issue (10.6 and 9%, respectively) discussed in direct health care professional letters of the Saudi Food and Drug Authority in June 2020. 22 Among hyperkalemic, hospitalized, adult, nondialysis patients in KSA, 31.0% used β-blockers, 30.3% ACE inhibitors, and 12.0% spironolactone/eplerenone, and the use of β-blockers correlated significantly with hyperkalemia. 15 In the survey in KSA, the most frequently stated causes of hyperkalemia were CKD (94%) and medications (87%), and 28% considered hyperkalemia being caused by RAASi treatment most of the time.…”

Section: Medical Conditions Associated With Hyperkalemiamentioning

confidence: 96%

“…Conditions and risk factors associated with hyperkalemia, including CKD, chronic metabolic conditions, HF, and medications are reflected in the populations with available prevalence data (Table 1). Indeed, hyperkalemia associated with RAASi medications and cardiac risks was the most frequent safety issue (10.6 and 9%, respectively) discussed in direct health care professional letters of the Saudi Food and Drug Authority in June 2020 22 . Among hyperkalemic, hospitalized, adult, nondialysis patients in KSA, 31.0% used β‐blockers, 30.3% ACE inhibitors, and 12.0% spironolactone/eplerenone, and the use of β‐blockers correlated significantly with hyperkalemia 15 …”

Section: Definition Prevalence and Risk Factors Of Hyperkalemiamentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC)

AlSahow

AbdulShafy

Al-Ghamdi

et al. 2023

J of Clinical Hypertension

View full text Add to dashboard Cite

Hyperkalemia is a frequent complication in patients with chronic kidney disease (CKD) or heart failure (HF) and associated with neuromuscular manifestations, changes in the electrocardiogram, and increased risk of mortality. While data on the prevalence and management of hyperkalemia in the gulf region are scarce, risk factors such as preference for potassium-rich foods (e.g., dates and dried fruits/vegetables), periods of intense fasting (e.g., Ramadan), and diabetes (an ancestor of CKD and HF) are common.Therefore, a panel of nephrologists and cardiologists from countries of the Gulf Cooperation Council (GCC) convened to collate and review available data on the prevalence, regional drivers, and current practice in the management of hyperkalemia in the region.Eventually, this review provides consensus recommendations on a balanced utilization of dietary and pharmacological options including new potassium binders for achieving and sustainably maintaining desirable serum potassium levels in countries of the GCC region. Alignment with regional habits and practice was a key aspect to facilitate the uptake of the recommendations into physicians' practice and patients' lives. K E Y W O R D Schronic kidney disease, heart failure, hyperkalemia, potassium binding INTRODUCTIONHyperkalemia is a frequent complication in chronic kidney disease (CKD) and heart failure (HF) patients, particularly those on reninangiotensin-aldosterone inhibitor (RAASi) therapy. 1,2 It is associ-All authors contributed equally to the preparation of this manuscript.

show abstract

Section: Medical Conditions Associated With Hyperkalemiamentioning

confidence: 96%

Section: Definition Prevalence and Risk Factors Of Hyperkalemiamentioning

confidence: 99%

Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC)

AlSahow

AbdulShafy

Al-Ghamdi

et al. 2023

J of Clinical Hypertension

View full text Add to dashboard Cite

show abstract

“…Many reviewed studies indicated the need of regular continuous medical education courses and workshops on PV and ADR reporting to be provided by the SFDA to HCPs throughout the country. We recommend that the regional PV volunteer coordinators assigned by the SFDA can oversee this task, engaging HCPs in professional discussion about ADR, ensure the dissemination of information, and assess the needed PV and ADR reporting training levels required by each institution [40]. A summary of the recommendations suggested to enhance stakeholders' contribution to ADR reporting is illustrated in Figure 2.…”

Section: Overview and Recommendationsmentioning

confidence: 99%

Pharmacovigilance in Saudi Arabia: A Narrative Review on Adverse Drug Reaction Reporting

J. Al Khabbaz

2023

Int. J. Res. Pharm. Sci.

View full text Add to dashboard Cite

Adverse drug reaction (ADR) reporting is an important aspect of pharmacovigilance (PV) in ensuring drug safety during the post-marketing surveillance phase. Currently, the National Pharmacovigilance Center (NPC) established by the Saudi Food and Drug Authority (SFDA) is the regulatory authority receiving ADR reports in Saudi Arabia. Spontaneous ADR reports from healthcare professionals and the public are received by the NPC through an electronic platform known as the Saudi Vigilance System. Signal analysis of the received ADR reports aids the decision-making initiatives related to the reported drugs. Stakeholders’ contribution to ADR reporting, and implementation of effective electronic platforms are important factors affecting the national PV performance. The concept of stakeholders reporting on ADR is relatively new in Saudi Arabia, especially to the public. In this narrative review the national studies describing the stakeholders’ knowledge, perception and barriers toward ADR reporting, and the incidence of ADR reporting by healthcare institutions in Saudi Arabia were evaluated. The findings indicate that more efforts are needed by the SFDA to educate stakeholders about the importance of ADR reporting. The study recommends ADR electronic systems integration between the SFDA and healthcare institutions to improve the frequency and quality of ADR reports, and regular feedback on decisions made about ADR reports should be provided by the SFDA to stakeholders to improve their awareness of the importance of ADR reporting and enhance their contribution to PV and ADR reporting process.

show abstract

Direct healthcare professional communications: A quantitative assessment study

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Cited by 2 publications

References 11 publications

Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC)

Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC)

Pharmacovigilance in Saudi Arabia: A Narrative Review on Adverse Drug Reaction Reporting

Contact Info

Product

Resources

About